Complications of pancreatic cancer resection

Dig Surg. 2002;19(2):138-46. doi: 10.1159/000052029.

Abstract

Pancreatic cancer is a common cause of cancer death in the developed world. Currently, resection is the only chance of long-term survival. The post-operative mortality in nonspecialist centres often exceeds 20% but is around 6% or less in specialist centres. The overall complication rate even in specialist centres is 18-54%. An analysis of eleven large series of pancreatic resections shows an incidence of common complications of 10.4% for fistula, 9.9% for delayed gastric emptying, 4.8% for bleeding, 4.8% for wound infection and 3.8% for intra-abdominal abscess. The median hospital stay is 13-18 days in different series. The re-operation rate varies from 4 to 9% with a mortality rate of 23 to 67%. Major complications are a significant factor in post-operative mortality, especially if they require re-operation. The use of octreotide or somatostatin to prevent complications is supported by several multicentre, double-blind, randomized controlled trials. The best way to improve outcome is to concentrate pancreatic cancer care in regional specialist centres.

Publication types

  • Review

MeSH terms

  • Anastomosis, Surgical
  • Gastric Emptying
  • Gastrointestinal Agents / therapeutic use
  • Humans
  • Length of Stay
  • Octreotide / therapeutic use
  • Pancreatectomy / adverse effects*
  • Pancreatic Fistula / etiology
  • Pancreatic Fistula / therapy
  • Pancreatic Neoplasms / surgery*
  • Reoperation
  • Treatment Outcome

Substances

  • Gastrointestinal Agents
  • Octreotide